FDA Declines to Disqualify Minneapolis Investigators and IRB From Running Trials

The FDA has turned down a citizen petition seeking that the investigators and the institutional review board (IRB) at Minneapolis, Minn.-based Hennepin County Medical Center (HCMC) be barred from conducting clinical trials.
Source: Drug Industry Daily